Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05508139
Other study ID # vestibular rehablitation
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 1, 2022
Est. completion date October 2024

Study information

Verified date August 2022
Source Assiut University
Contact Abdelmawla kassem
Phone 01019319054
Email Abelmawla.Hammad@aun.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

1. To assess the criteria of positional vertigo in vestibular migraine patients 2. To assess the effect of vestibular rehabilitation therapy in management of positional vertigo in vestibular migraine patients


Description:

Vestibular migraine(VM) is a variant of migraine where the patient reports recurrent vertigo lasting minutes to days. The migraine headache component may be present with associated light and sound sensitivity but the vestibular symptoms are usually prominent . Migraine prophylaxis has been shown to provide some benefit to help to prevent or abort acute attacks of vertigo . Vestibular migraine has a life time prevalence of about 1 % and a 1-year prevalence of 0.9 % in the general population and accounts for about 7% of patients seen in dizziness clinics and 9 % of patients seen in migraine clinics . The International Headache Society and the International Barany Society for Neuro-otology have developed a consensus document with diagnostic criteria for VM . This diagnosis was included in the appendix of the new international classification of headache disorders (ICHD)-3 beta version of headache classification . Diagnostic criteria The criteria for VM combine the typical signs and symptoms of migraine with the exclusion criteria of other disorders that also elicit vestibular signs . As in migraine without aura, a diagnosis of VM mainly depends on the patient history, for so far there are no clinically useful biomarkers. Vestibular migraine diagnostic criteria International Bárány Society for Neuro-Otology and the International Headache Society (2012):- A. At least five episodes fulfilling criteria C and D B. A current or past history of migraine without aura or migraine with aura C. Vestibular symptoms of moderate or severe intensity, lasting 5 min to 72 hours D. At least 50 % of episodes are associated with at least one of the following three migrainous features - Headache with at least two of the following four characteristics - Unilateral location - Pulsating quality - Moderate or severe intensity - Aggravation by routine physical activity - Photophobia and phonophobia - Visual aura The mechanisms underlying vestibular dysfunction that are related to migraine still need further study and clarification. One explanation proposed is a parallel activation of vestibular and cranial nociceptive pathways. Experimental studies have demonstrated that trigeminal and vestibular ganglion cells share neurochemical properties and express serotonin, capsaicin, and purinergic receptors. Nociceptive and vestibular afferents with neurochemical similarities converge in brainstem structures like the parabrachial nucleus, the raphe nuclei, and the locus coeruleus. All of these structures play an important role in modulating the sensitivity of pain pathways. The vestibular rehabilitation become one of the main treatment modalities for patients suffering from vestibular dysfunction, patients are referred for vestibular rehabilitation therapy with aim of helping to relieve them of symptoms of dizziness ,gaze instability, disequilibrium and to improve their functional status.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date October 2024
Est. primary completion date September 2024
Accepts healthy volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Age: from 20 years to 50 years old. - Sex: male or female. - Vestibular migraine Exclusion Criteria: 1. Evidence of neurological or psychiatric illness. 2. Patients with other types of headache. 3. Evidence of active middle ear disease. 4. History of head trauma, surgery or ototoxic drug therapy 5. Exclude other causes of vestibular disorder

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (1)

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients quantify the effects of vestibular migrine some of them are as following dizzness handicap inventory through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Recruiting NCT04417361 - Galcanezumab for Vestibular Migraine Phase 2
Enrolling by invitation NCT05396482 - Assesment of Hearing in Patients With Vestibular Migra
Completed NCT03979677 - Effects of Lifestyle Modification on Vestibular Migraine N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Not yet recruiting NCT05914207 - Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent N/A
Enrolling by invitation NCT06417684 - Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine Early Phase 1
Recruiting NCT04939922 - China Headache Registry Study
Recruiting NCT05472675 - Local Sensory Nerve Block in the Treatment of Vestibular Migraine N/A
Recruiting NCT05418218 - International Headache Registry Study
Suspended NCT04026516 - CAVA: Dizziness Trial N/A
Withdrawn NCT03578354 - 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine Phase 2
Completed NCT02350985 - Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine Phase 4
Completed NCT03417596 - Vestibular Rehabilitation in Patients With Vestibular Migraine N/A
Not yet recruiting NCT04664088 - Acupuncture for Prophylaxis of Vestibular Migraine N/A
Enrolling by invitation NCT06267924 - SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines N/A
Completed NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand N/A
Completed NCT02447991 - Rizatriptan for Episodic Dizziness in Vestibular Migraine Phase 2/Phase 3
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Completed NCT01669304 - Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness Phase 1